The serious ill would be B's target audience not case numbers. Many posting here are like the media hyping an event... What percentage of cases would be a sales target? 2 to 3 percent? So any partner will weigh costs of phase 3 and distribution versus potential revenues... And I'm sure those revenues would be shared with IPIX... Again, not an easy sale for a partnership and why we've seen zero so far. Leo most likely will have to go solo with B advancement and why a sale of IPIX makes the most sense if data is strong... IPIX has no structure/funding to advance B/C past P2.